Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: Results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy)
- 1 September 1990
- journal article
- clinical trial
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 4 (5) , 1047-1068
- https://doi.org/10.1007/bf02018315
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Compensatory Enlargement of Human Atherosclerotic Coronary ArteriesNew England Journal of Medicine, 1987
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Comparison of pathologic and angiographic findings in a porcine preparation of coronary atherosclerosis.Circulation, 1985
- Diet, Lipoproteins, and the Progression of Coronary AtherosclerosisNew England Journal of Medicine, 1985
- The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.Circulation, 1984
- Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.Circulation, 1984
- The anatomic evolution of coronary artery disease demonstrated by coronary arteriography in 256 nonoperated patients.Circulation, 1981
- Quantitative difference in "critical" stenosis between right and left coronary artery in man.Circulation, 1980
- A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart AssociationCirculation, 1975